These findings suggest that NRF2 activation may offer a strategy to limit VEEV induced endothelial dysfunction by enhancing redox control and reducing inflammatory damage without suppressing essential antiviral pathways. The gene discussed is NFE2L2; the disease is endothelial dysfunction.